Israel’s Frutarom has signed an agreement for the acquisition of Acatris and its affiliates in the US, Belgium and the Netherlands, known collectively as Acatris Health, for EUR10.5m (US$13.34m).

Acatris Health, a global health ingredients company, is a subsidiary of the Dutch Royal Schouten Group NV. The company develops, produces, sells and markets botanical ingredients for the dietary supplement and functional food markets.

The Acatris Health LifeLine product range, which include Linumlife, Fenulife, and Soylife, is sold to more than 450 leading companies in the food supplement, functional food and cosmetic markets, mostly in Western Europe and the US.

Frutarom said that the acquisition of Acatris Health was an important strategic development that represents another step in the implementation of the company’s growth strategy.